Breaking Biotech

Does the Hepatitis B (HepB) vaccine used in the United States stop infection and transmission of Hepatitis B in a school setting? Answer: HepB is mandated to attend school in most states and the justification for these rights-crushing mandates is to prevent transmission of Hepatitis B in the school setting. So, on behalf of @ICANdecide, we sent a Freedom of Information Act request to CDC asking for “documentation sufficient to reflect any case(s) of transmission of Hepatitis B in an elementary, middle, or high school setting.” In response, the CDC explained that: “A search of our [CDC] records failed to reveal any documents” of “transmission of Hepatitis B in an elementary, middle or high school setting.”* This is because Hepatitis B is a bloodborne illness, typically transmitted by sex workers or drug users sharing needles — not activities that occur in a classroom setting. And of course, at the risk of stating the obvious, just because someone hasn’t gotten a HepB vaccine doesn’t mean they have Hepatitis B. It is also noteworthy that, as the CDC explains, “almost all children 6 years and older and adults infected with the hepatitis B virus recover completely and do not develop chronic infection.”** And (you may need to sit down for this one), the clinical trials for HepB vaccines, injected at birth and again at 1 and 6 months, plainly did not show they were safe because: --Recombivax HB (Merck) was licensed for babies based on trials with no placebo control & 5 days of safety monitoring after injection; and --Engerix B (GSK) was licensed for babies based on trials with no placebo control & 4 days of safety monitoring after injection. Sources: *icandecide.org/wp-content/upl… **cdc.gov/hepatitis-b/ ***fda.gov/media/74274/do… (Recombivax HB package insert, see Section 6.1) ****fda.gov/media/119403/d… (Engerix B package insert, see Section 6.1)